Pallas Health vs Ro.co: Oral Wegovy vs compounded semaglutide plans
Pallas Health vs Ro.co answers whether you want clinician-selected brand or compounded injectables from a 100% online program or an oral FDA-approved option. Early verdict: choose Pallas for clinician access to both brand pens and compounded semaglutide/tirzepatide with provider care included in plan pricing; choose Ro.co if you need the Wegovy pill or an injection-free FDA-approved oral GLP-1 and a $39 get-started option.
Explore Pallas Health plans and clinician review
Key difference 1: Medication types and regulatory status
Pallas Health offers both FDA-approved brand-name GLP-1s such as Wegovy, Ozempic, Zepbound and Mounjaro, and clinician-personalized compounded semaglutide or tirzepatide prepared in the USA. The source notes that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Ro.co is the only mainstream platform on the list offering the Wegovy pill, the FDA-approved oral GLP-1, a finished medication rather than a compounded product. Ro emphasizes the regulatory assurance of an FDA-approved finished product.
Key difference 2: Pricing entry point and ongoing cost structure
Pallas lists compounded semaglutide at $139 for the first month then $597 every 12 weeks, a $199/month average, and compounded tirzepatide at $179 first month then $897 every 12 weeks, a $299/month average. Pallas also shows cash-pay pricing for brand-name pens (examples listed). Ro.co advertises you can get started online for just $39, with ongoing branded medication pricing varying by plan and generally higher than compounded alternatives. Ro states pricing is disclosed before you complete the consultation.
Get started with Ro.co for $39
Key difference 3: Care model and platform experience
Pallas Health is 100 percent online and asynchronous in most states, with a US-licensed clinician reviewing health history to personalize a plan; a video visit is required in seven states plus Washington, D.C. Pallas includes clinician review, ongoing check-ins and care-team messaging in the plan price with no separate membership fee. Ro.co is described as an established full-service telehealth platform that prescribes FDA-approved medications after a licensed clinician review and highlights platform trust and transparent pricing before consultation.
Comparison table: Pallas Health vs Ro.co
| Criteria | Pallas Health | Ro.co |
|---|---|---|
| Medication options | Brand-name GLP-1s and compounded semaglutide/tirzepatide | Wegovy pill (FDA-approved oral GLP-1) and branded options |
| Regulatory note | Compounded meds are not FDA-approved; brand options listed | Offers FDA-approved finished oral Wegovy pill |
| Starting price | Compounded semaglutide $139 first month | Get started online for $39 |
| Ongoing pricing model | Compounded semaglutide renews $597 per 12 weeks (avg $199/mo) | Ongoing branded pricing varies by plan; disclosed before consultation |
| Care included | Provider care, check-ins and messaging included in plan price | Licensed clinician review; pricing transparency before consultation |
Other practical differences
Shipping and fulfillment: Pallas advertises free expedited discreet shipping and notes compounded medications are prepared by US-licensed compounding pharmacies. Ro.co captured information did not include shipping details on the captured page. Eligibility and payment: Pallas is cash-pay only and does not bill insurance; treatment eligibility is determined by a US-licensed clinician. Ro.co notes treatment is available only when a licensed clinician determines it is medically appropriate and that ongoing branded medication costs can be high.
See Pallas pricing and clinician eligibility
Regulatory reminder
Both sources state that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Ro.co emphasizes access to an FDA-approved oral option; Pallas emphasizes clinician choice between brand-name pens and compounded preparations.
Learn about the Wegovy pill on Ro.co
Conclusion: Choose based on medication format, price, and care inclusion
For a direct choice in the Pallas Health vs Ro.co comparison: Pallas is focused on giving a clinician the ability to select between brand-name pens and compounded injectables within a single intake, with provider care included in the plan price and compounded semaglutide from $139 first month then $199/mo avg. Ro.co is the standout if you need the Wegovy pill, the FDA-approved oral GLP-1, or prefer a $39 entry point and an injection-free path with pricing disclosed before consultation.
Choose Pallas Health if you want clinician access to both brand-name GLP-1s and US-compounded semaglutide or tirzepatide, all-in plan pricing that includes provider care, and free expedited shipping where offered.
Choose Ro.co if you need the Wegovy pill, prefer an FDA-approved oral GLP-1 and want to start online for $39 with branded pricing disclosed before your consultation.